Strong Biotechnologies adjusts convertible bond price after dividend payout

Beijing Strong Biotechnologies, Inc. has adjusted the conversion price of its "Strong Bond" convertible corporate bonds to RMB 16.68 per share, effective September 5, 2025. This adjustment follows the company's 2025 semi-annual profit distribution plan, which involved a cash dividend payout. The previous conversion price was RMB 16.98 per share, adjusted from an initial RMB 17.35 per share after a cash dividend of RMB 0.3975903 per share.

The company's 2025 semi-annual profit distribution involved a cash dividend of RMB 3.000000 per 10 shares (tax inclusive) for a total of RMB 174,829,363.20. The actual cash dividend per share was calculated as RMB 0.2981865, based on the total share capital after accounting for treasury shares. This adjustment aligns with the terms outlined in the bond's prospectus.

China International Capital Corporation Limited, as the trustee for these bonds, has confirmed that the adjustment complies with the terms of the bond prospectus and does not materially impact the company's daily operations or solvency. The trustee will continue to monitor the bond's principal and interest payments and other significant matters affecting bondholders' interests.